Works matching AU Figlin, Robert

Results: 100

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma.

Published in:

2011

By:

Pal, Sumanta;
Figlin, Robert;
Pal, Sumanta Kumar;
Figlin, Robert A

Publication type:

journal article

Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program.

Published in:

Oncology, 2010, v. 78, n. 5/6, p. 340, doi. 10.1159/000320223

By:

Bukowski, Ronald M.;
Stadler, Walter M.;
McDermott, David F.;
Dutcher, Janice P.;
Knox, Jennifer J.;
Miller Jr., Wilson H.;
Hainsworth, John D.;
Henderson, Charles A.;
Hajdenberg, Julio;
Kindwall-Keller, Tamila L.;
Ernstoff, Marc S.;
Drabkin, Harry A.;
Curti, Brendan D.;
Chu, Luis;
Ryan, Christopher W.;
Hotte, Sebastien J.;
Chenghua Xia;
Cupit, Lisa;
Figlin, Robert A.

Publication type:

Article

Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG‐PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.

Published in:

Oncologist, 2019, v. 24, n. 12, p. e1460, doi. 10.1634/theoncologist.2018-0882

By:

Neeman, Elad;
Gresham, Gillian;
Ovasapians, Navasard;
Hendifar, Andrew;
Tuli, Richard;
Figlin, Robert;
Shinde, Arvind

Publication type:

Article

Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma.

Published in:

Oncologist, 2017, v. 22, n. 1, p. 41, doi. 10.1634/theoncologist.2016-0197

By:

Motzer, Robert J.;
Escudier, Bernard;
Gannon, Andrew;
Figlin, Robert A.

Publication type:

Article

The role of molecular markers in the staging of renal cell carcinoma.

Published in:

BJU International, 2007, v. 99, p. 1208, doi. 10.1111/j.1464-410X.2007.06812.x

By:

Leppert, John T.;
Pantuck, Allan J.;
Figlin, Robert A.;
Belldegrun, Arie S.

Publication type:

Article

Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.

Published in:

BJU International, 2007, v. 99, n. 4, p. 821, doi. 10.1111/j.1464-410X.2006.06729.x

By:

Klatte, Tobias;
Chung, JinSoo;
Leppert, John T.;
Lam, John S.;
Pantuck, Allan J.;
Figlin, Robert A.;
Belldegrun, Arie S.

Publication type:

Article

Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.

Published in:

BJU International, 2005, v. 96, n. 4, p. 483, doi. 10.1111/j.1464-410X.2005.05670.x

By:

Lam, John S.;
Leppert, John T.;
Belldegrun, Arie S.;
Figlin, Robert A.

Publication type:

Article

Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.

Published in:

BJU International, 2005, v. 96, n. 3, p. 281, doi. 10.1111/j.1464-410X.2005.05615.x

By:

Leppert, John T.;
Lam, John S.;
Pantuck, Allan J.;
Figlin, Robert A.;
Belldegrun, Arie S.

Publication type:

Article

<sup>18</sup>F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib.

Published in:

Journal of Nuclear Medicine, 2011, v. 52, n. 11, p. 1684, doi. 10.2967/jnumed.111.095257

By:

Benz, Matthias R.;
Herrmann, Ken;
Walter, Franziska;
Garon, Edward B.;
Reckamp, Karen L.;
Figlin, Robert;
Phelps, Michael E.;
Weber, Wolfgang A.;
Czernin, Johannes;
Allen-Auerbach, Martin S.

Publication type:

Article

Monitoring Cancer Treatment with PET/CT: Does It Make a Difference?

Published in:

Journal of Nuclear Medicine, 2007, v. 48, n. 1, p. 36S

By:

Weber, Wolfgang A.;
Figlin, Robert

Publication type:

Article

Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: The ucla experience.

Published in:

Journal of Surgical Oncology, 1995, v. 60, n. 4, p. 262, doi. 10.1002/jso.2930600410

By:

Lee, Jeffrey D.;
Perez, Sol;
Wang, He-Jing;
Figlin, Robert A.;
Holmes, E. Carmack

Publication type:

Article

Targeted Therapies for Metastatic Renal Cell Carcinoma: An Overview of Toxicity and Dosing Strategies.

Published in:

Oncologist, 2008, v. 13, n. 10, p. 1084, doi. 10.1634/theoncologist.2008-0120

By:

Hutson, Thomas E.;
Figlin, Robert A.;
Kuhn, John G.;
Motzer, Robert J.

Publication type:

Article

Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.

Published in:

2009

By:

Dutcher JP;
de Souza P;
McDermott D;
Figlin RA;
Berkenblit A;
Thiele A;
Krygowski M;
Strahs A;
Feingold J;
Hudes G;
Dutcher, Janice P;
de Souza, Paul;
McDermott, David;
Figlin, Robert A;
Berkenblit, Anna;
Thiele, Alexandra;
Krygowski, Mizue;
Strahs, Andrew;
Feingold, Jay;
Hudes, Gary

Publication type:

journal article

Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies.

Published in:

Medical Oncology, 2009, v. 26, n. 2, p. 202, doi. 10.1007/s12032-009-9177-0

By:

Janice Dutcher;
Paul de Souza;
David McDermott;
Robert Figlin;
Anna Berkenblit;
Alexandra Thiele;
Mizue Krygowski;
Andrew Strahs;
Jay Feingold;
Gary Hudes

Publication type:

Article

Recent Advances in the Medical Treatment of Recurrent or Metastatic Renal Cell Cancer.

Published in:

Drugs, 2017, v. 77, n. 1, p. 17, doi. 10.1007/s40265-016-0665-1

By:

Kumbla, Rekha;
Figlin, Robert;
Posadas, Edwin

Publication type:

Article

Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 739, doi. 10.1007/s00280-014-2539-0

By:

Motzer, Robert;
Hutson, Thomas;
Hudes, Gary;
Figlin, Robert;
Martini, Jean-Francois;
English, Patricia;
Huang, Xin;
Valota, Olga;
Williams, J.

Publication type:

Article

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.

Published in:

2014

By:

Harmon, Charles S;
Deprimo, Samuel E;
Figlin, Robert A;
Hudes, Gary R;
Hutson, Thomas E;
Michaelson, M Dror;
Négrier, Sylvie;
Kim, Sindy T;
Huang, Xin;
Williams, J Andrew;
Eisen, Tim;
Motzer, Robert J

Publication type:

journal article

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 151, doi. 10.1007/s00280-013-2333-4

By:

Harmon, Charles;
DePrimo, Samuel;
Figlin, Robert;
Hudes, Gary;
Hutson, Thomas;
Michaelson, M.;
Négrier, Sylvie;
Kim, Sindy;
Huang, Xin;
Williams, J.;
Eisen, Tim;
Motzer, Robert

Publication type:

Article

Targeting angiogenesis in renal cell carcinoma.

Published in:

Expert Opinion on Pharmacotherapy, 2013, v. 14, n. 16, p. 2221, doi. 10.1517/14656566.2013.832202

By:

Posadas, Edwin M;
Limvorasak, Suwicha;
Sharma, Shaleekha;
Figlin, Robert A

Publication type:

Article

Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer.

Published in:

2020

By:

Vail, Eric;
Song, Jianbo;
Xu, Jing;
Frye, Joseph S.;
Kim, Jong Taek;
Pao, Andy;
Schreck, Rhona;
Aguiluz, Angela S.;
Zhang, Wenjuan;
Alkan, Serhan;
Mita, Alain;
Mita, Monica;
Figlin, Robert A.;
Engman, David M.;
Lopategui, Jean R.

Publication type:

journal article

Targeted therapies for renal cell carcinoma: understanding their impact on survival.

Published in:

Targeted Oncology, 2010, v. 5, n. 2, p. 131, doi. 10.1007/s11523-010-0145-6

By:

Pal, Sumanta;
Figlin, Robert

Publication type:

Article

Deciphering the anticancer mechanisms of sunitinib.

Published in:

Cancer Biology & Therapy, 2010, v. 10, n. 7, p. 712, doi. 10.4161/cbt.10.7.13130

By:

Pal, Sumanta Kumar;
Figlin, Robert A.;
Hua Yu

Publication type:

Article

Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells.

Published in:

Molecular Cancer, 2003, v. 2, p. 35, doi. 10.1186/1476-4598-2-35

By:

Riedl, Karen;
Baratelli, Felicita;
Batra, Raj K.;
Seok Chul Yang;
Jie Luo;
Escuadro, Brian;
Figlin, Robert;
Strieter, Robert;
Sharma, Sherven;
Dubinett, Steven

Publication type:

Article

Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma.

Published in:

BJU International, 2011, v. 108, n. 5, p. 665, doi. 10.1111/j.1464-410X.2010.09957.x

By:

Benedict, Ágnes;
Figlin, Robert A.;
Sandström, Per;
Harmenberg, Ulrika;
Ullén, Anders;
Charbonneau, Claudie;
Sandin, Rickard;
Remák, Edit;
Hariharan, Subramanian;
Négrier, Sylvie

Publication type:

Article

Annexin-I as a potential target for green tea extract induced actin remodeling.

Published in:

International Journal of Cancer, 2007, v. 120, n. 1, p. 111, doi. 10.1002/ijc.22164

By:

Xiao, Gui-Shan;
Jin, Yu-Sheng;
Lu, Qing-Yi;
Zhang, Zuo-Feng;
Belldegrun, Arie;
Figlin, Robert;
Pantuck, Allan;
Yen, Yun;
Li, Frederick;
Rao, JianYu

Publication type:

Article

Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients.

Published in:

International Journal of Cancer, 2003, v. 107, n. 2, p. 256, doi. 10.1002/ijc.11379

By:

Sylvia M. Kiertscher;
Barbara J. Gitlitz;
Robert A. Figlin;
Michael D. Roth

Publication type:

Article

Treatment options in metastatic renal cell carcinoma: focus on mtor inhibitors.

Published in:

2010

By:

Pal, Sumanta Kumar;
Figlin, Robert A.

Publication type:

Journal Article

Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors.

Published in:

Clinical Medicine Insights: Oncology, 2010, n. 4, p. 43, doi. 10.4137/CMO.S1590

By:

Kumar Pal, Sumanta;
Figlin, Robert A.

Publication type:

Article

Novel Treatment Advances and Approaches in the Management of Advanced Renal Cell Carcinoma (RCC).

Published in:

Journal of Managed Care Medicine, 2018, v. 21, n. 4, p. 79

By:

Figlin, Robert A.

Publication type:

Article

Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment.

Published in:

1991

By:

Ross, Helen J.;
Moy, Larry A.;
Kaplan, Richard;
Figlin, Robert A.;
Ross, H J;
Moy, L A;
Kaplan, R;
Figlin, R A

Publication type:

journal article

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Published in:

1989

By:

Ganz, Patricia A.;
Figlin, Robert A.;
Haskell, Charles M.;
la Soto, Nancy;
Siau, Jessie;
Ganz, P A;
Figlin, R A;
Haskell, C M;
La Soto, N;
Siau, J

Publication type:

journal article

Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer.

Published in:

1988

By:

Ganz, Patricia A.;
Haskell, Charles M.;
Figlin, Robert A.;
Soto, Nancy La;
Siau, Jessie;
Ganz, P A;
Haskell, C M;
Figlin, R A;
La Soto, N;
Siau, J

Publication type:

journal article

Interferon in renal cell carcinoma. The UCLA experience.

Published in:

Cancer (0008543X), 1987, v. 59, n. S3, p. 610, doi. 10.1002/1097-0142(19870201)59:3+<610::AID-CNCR2820591306>3.0.CO;2-F

By:

Sarna, Gregory;
Figlin, Robert;
de Kernion, Jean

Publication type:

Article

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.

Published in:

Investigational New Drugs, 2014, v. 32, n. 1, p. 178, doi. 10.1007/s10637-013-0045-6

By:

Rosenberg, Jonathan;
Bambury, Richard;
Allen, Eliezer;
Drabkin, Harry;
Lara, Primo;
Harzstark, Andrea;
Wagle, Nikhil;
Figlin, Robert;
Smith, Gregory;
Garraway, Levi;
Choueiri, Toni;
Erlandsson, Fredrik;
Laber, Damian

Publication type:

Article

Novel approaches in the therapy of metastatic renal cell carcinoma.

Published in:

World Journal of Urology, 2005, v. 23, n. 3, p. 202, doi. 10.1007/s00345-004-0466-0

By:

Lam, John;
Leppert, John T.;
Belldegrun, Arie S.;
Figlin, Robert A.

Publication type:

Article

Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex.

Published in:

World Journal of Urology, 2000, v. 18, n. 2, p. 152, doi. 10.1007/s003450050189

By:

Hoffman, David M. J.;
Figlin, Robert A.

Publication type:

Article

The Evolving Immunotherapeutic Landscape in Renal Cell Carcinoma.

Published in:

Oncology Issues, 2021, v. 36, n. 2, p. 74, doi. 10.1080/10463356.2021.1879589

By:

Figlin, Robert A.;
Mohs, Jocelyn;
Wood, Laura S.

Publication type:

Article

Immune gene therapy for kidney cancer: the search for a magic trigger

Published in:

Molecular Therapy, 2003, v. 7, n. 2, p. 153, doi. 10.1016/S1525-0016(02)00048-5

By:

Kim, Hyung L.;
Belldegrun, Arie S.;
Figlin, Robert A.

Publication type:

Article

Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: New strategies for overcoming resistance to VEGFR and mTORC1 inhibitors.

Published in:

International Journal of Cancer, 2013, v. 133, n. 4, p. 788, doi. 10.1002/ijc.28023

By:

Figlin, Robert A.;
Kaufmann, Isabelle;
Brechbiel, Jillian

Publication type:

Article

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum].

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5167, doi. 10.2147/ott.s315170

By:

LeVee, Alexis;
Lin, Ching Ying;
Posadas, Edwin;
Figlin, Robert;
Bhowmick, Neil A;
Vizio, Dolores Di;
Ellis, Leigh;
Rosser, Charlos J;
Freeman, Michael R;
Theodorescu, Dan;
Freedland, Stephen J;
Gong, Jun

Publication type:

Article

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4819, doi. 10.2147/OTT.S315170

By:

LeVee, Alexis;
Lin, Ching Ying;
Posadas, Edwin;
Figlin, Robert;
Bhowmick, Neil A;
Vizio, Dolores Di;
Ellis, Leigh;
Rosser, Charlos J;
Freeman, Michael R;
Theodorescu, Dan;
Freedland, Stephen J;
Gong, Jun

Publication type:

Article

Tumor necrosis factor induces hemorrhagic necrosis of a sarcoma.

Published in:

1989

By:

Robertson, Paul A.;
Ross, Helen J.;
Figlin, Robert A.;
Robertson, P A;
Ross, H J;
Figlin, R A

Publication type:

journal article

Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.

Published in:

Cancer (0008543X), 2015, v. 121, n. 18, p. 3298, doi. 10.1002/cncr.29480

By:

Reckamp, Karen L.;
Koczywas, Marianna;
Cristea, Mihaela C.;
Dowell, Jonathan E.;
Wang, He‐Jing;
Gardner, Brian K.;
Milne, Ginger L.;
Figlin, Robert A.;
Fishbein, Michael C.;
Elashoff, Robert M.;
Dubinett, Steven M.

Publication type:

Article

Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma.

Published in:

Cancer (0008543X), 2014, v. 120, n. 12, p. 1871, doi. 10.1002/cncr.28660

By:

Cella, David;
Davis, Mellar P.;
Négrier, Sylvie;
Figlin, Robert A.;
Michaelson, M. Dror;
Bushmakin, Andrew G.;
Cappelleri, Joseph C.;
Sandin, Rickard;
Korytowsky, Beata;
Charbonneau, Claudie;
Matczak, Ewa;
Motzer, Robert J.

Publication type:

Article

Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?

Published in:

2014

By:

Pal, Sumanta K.;
Figlin, Robert A.

Publication type:

Editorial

Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.

Published in:

Cancer (0008543X), 2012, v. 118, n. 24, p. 6055, doi. 10.1002/cncr.27668

By:

Cho, Daniel C.;
Hutson, Thomas E.;
Samlowski, Wolfram;
Sportelli, Peter;
Somer, Brad;
Richards, Paul;
Sosman, Jeffrey A.;
Puzanov, Igor;
Michaelson, M. Dror;
Flaherty, Keith T.;
Figlin, Robert A.;
Vogelzang, Nicholas J.

Publication type:

Article

Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma.

Published in:

Cancer (0008543X), 2010, v. 116, n. 18, p. 4256, doi. 10.1002/cncr.25219

By:

Motzer, Robert J.;
Escudier, Bernard;
Oudard, Stephane;
Hutson, Thomas E.;
Porta, Camillo;
Bracarda, Sergio;
Grenwald, Viktor;
Thompson, John A.;
Figlin, Robert A.;
Hollaender, Norbert;
Kay, Andrea;
Ravaud, Alain

Publication type:

Article

The value of surrogate endpoints for predicting real-world survival across five cancer types.

Published in:

2016

By:

Shafrin, Jason;
Brookmeyer, Ron;
Peneva, Desi;
Park, Jinhee;
Zhang, Jie;
Figlin, Robert A.;
Lakdawalla, Darius N.

Publication type:

journal article

Targeted therapy for sarcomas.

Published in:

Biologics: Targets & Therapy, 2014, v. 8, p. 91, doi. 10.2147/BTT.S26555

By:

Forscher, Charles;
Mita, Monica;
Figlin, Robert

Publication type:

Article

Surveillance following radical or partial nephrectomy for renal cell carcinoma.

Published in:

Current Urology Reports, 2005, v. 6, n. 1, p. 7, doi. 10.1007/s11934-005-0062-x

By:

Lam, John;
Leppert, John;
Figlin, Robert;
Belldegrun, Arie

Publication type:

Article